Source: International Congress 2017 – Insight into the pathogenesis of emphysema and pneumonia
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Y. Tian (Zhengzhou, China). Bufei Yishen granules and it combined with acupoint sticking therapy suppresses inflammation in COPD rats: via JNK/p38 signaling pathway. 3928

Member's Comments

No comment yet.

Related content which might interest you: 6-aminonicotinamide ameliorates pulmonary fibrosis by suppressing the TGF-beta1 activated Smad signalling pathway Source: Virtual Congress 2020 – Translational therapeutic advances Year: 2020 Amifostine reduces lipopolysaccharide-induced lung dysfunction via suppression of redox-sensitive inflammatory signaling Source: Annual Congress 2008 - Animal models of pulmonary fibrosis: mechanisms and therapies Year: 2008 Inhibition of VEGF blocks the activation of TGF-β1 through a PI3K/Akt signaling pathway in allergic airway disease of mice Source: Annual Congress 2007 - Current issues in airway physiology, pharmacology and monitoring Year: 2007 Effect of p38 MAPK inhibition on corticosteroid suppression of cytokine release in severe asthma Source: Eur Respir J 2010; 35: 750-756 Year: 2010 Korean Red Ginseng inhibits diesel exhaust particles-induced MUC5AC/B expression and inflammation through suppressing TLR4 and NF-kB signaling pathway in vitro and in vivo Source: International Congress 2019 – Effects of environmental exposures in lung pathology and the underlying mechanisms Year: 2019 Insulin resistance exacerbates lung inflammation in obese patients via PI3K/Akt signaling pathway Source: International Congress 2019 – Understanding the mechanisms underlying airway diseases Year: 2019 Bufei Jianpi granules decrease skeletal muscular cell apoptosis via improving mitochondrial dysfunction in rats with chronic obstructive pulmonary disease Source: International Congress 2017 – Towards better treatments for lung disease: experimental pharmacology Year: 2017 An extract from a traditional Chinese medicine polyherbal formula and its main active ingredients regulate cAMP signaling: A potential treatment for lung fibrosis Source: Annual Congress 2012 - Fibrogenesis between epithelial injury and fibroblast proliferation Year: 2012 CHF 6001 inhibits nuclear translocation of NF-?B in LPS-induced lung inflammation in mice Source: International Congress 2017 – Towards better treatments for lung disease: experimental pharmacology Year: 2017 Effect of Shenqi Fuzheng injection on expression of fractalkine in lipopolysaccharide-induced acute lung injury Source: Eur Respir J 2007; 30: Suppl. 51, 146s Year: 2007 Differential anti-inflammatory effects of budesonide and a p38 MAPK inhibitor AZD7624 on COPD pulmonary cells Source: International Congress 2018 – Preclinical pharmacology: novel targets in airway inflammation, narrowing and neural control Year: 2018 Resolvin D1 attenuates lung inflammation in LPS induced-ALI partly through PPARγ/NF-κB pathway Source: Annual Congress 2011 - Anti-inflammatory strategies in acute lung injury Year: 2011 TSC1/mTOR pathway promotes hypoxia-induced pulmonary hypertension in mice Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms, animal models and experimental treatments Year: 2012 rHuKGF optimistically attenuates MAPK/ERK mediated cell proliferation pathway in emphysematous lungs Source: Annual Congress 2013 –Novel in vitro and animal models to study lung diseases Year: 2013 AZD7624, an inhaled p38 inhibitor for COPD, attenuates lung and systemic inflammation after LPS Challenge in humans Source: International Congress 2015 – Advances in the future treatment of COPD Year: 2015 Anti-inflammatory effect of hypoxic signaling suppression in the severe COPD model. Source: International Congress 2018 – COPD: novel pathological mechanisms in the airway epithelium Year: 2018 Maintenance of IRF1 by MAPK inhibition: A mechanism by which DUSP1 reduces glucocorticoid inhibition of CXCL10 Source: International Congress 2016 – Airway pharmacology: drug targets and mode of action Year: 2016 Role of RhoA/Rho-kinase pathway in the regulation of eNOS activity in COPD patients Source: Annual Congress 2010 - Pathobiology of pulmonary hypertension Year: 2010 Bufei Yishen granules decrease inflammation and extracellular matrix deposition in airway remodeling in chronic obstructive pulmonary disease rats Source: International Congress 2017 – Towards better treatments for lung disease: experimental pharmacology Year: 2017 Analysis of cytokine signaling pathway JAK-STAT through their activation in patients with asthma Source: Annual Congress 2008 - Novel mechanisms and targets of molecular pulmonary pathology Year: 2008